Overall rank by patents
#30,324
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center
USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
9
Total patents granted
10
CPC technology areas
10.3
Avg claims per patent
-
5-year filing velocity
The verdict
THE holds 9 US patents across 10 technology areas, rank #30,324 of 50,000 tracked assignees.
- #30,324
- of 50,000 US assignees by volume
- Top 40%
- by Innovation Score (38.7/100)
- 10.3
- avg claims per patent
Portfolio overview
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center has been granted 9 US utility patents between 2020 and 2024, placing THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center at rank #30,324 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center is one of the more focused assignees in the PatentsView dataset. By volume, THE sits between THE Government OF THE United States OF America AS Represent BY THE Secretary OF THE AIR Force (9 patents, rank #30,320) and Theaprin Pharmaceuticals, Inc. (9 patents, rank #30,328) - the closest US assignees by grant volume. The composite Innovation Score of 38.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 9 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's 10.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center against peers pursuing similar technology classes.
Who files at THE's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- THE Government OF…
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENT BY THE SECRETARY OF THE AIR FORCE
9 patents
- THE JOY Factory
THE JOY FACTORY, INC.
9 patents
- THE KUN Shoulder…
THE KUN SHOULDER REST INC.
9 patents
- THE Laryngeal MASK
THE LARYNGEAL MASK COMPANY LIMITED
9 patents
- THE Monadnock
THE MONADNOCK COMPANY
9 patents
- THE Reynolds AND…
THE REYNOLDS AND REYNOLDS COMPANY
9 patents
- THE Surgical Inte…
THE SURGICAL COMPANY INTERNATIONAL B.V.
9 patents
- Theaprin Pharmace…
THEAPRIN PHARMACEUTICALS, INC.
9 patents
- THE Lundquist Ins… ◀
THE LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
9 patents
What this shows THE holds 9 patents at rank #30,324, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near THE
By rank, the assignees closest to #30,324 in granted patent volume.
- THE Government OF THE United States OF America AS Represent BY THE Secretary OF THE AIR Force #30,320 · 9 patents
- THE JOY Factory, Inc. #30,321 · 9 patents
- THE KUN Shoulder REST Inc. #30,322 · 9 patents
- THE Laryngeal MASK Company Limited #30,323 · 9 patents
- THE Monadnock Company #30,325 · 9 patents
- THE Reynolds AND Reynolds Company #30,326 · 9 patents
- THE Surgical Company International B.v. #30,327 · 9 patents
- Theaprin Pharmaceuticals, Inc. #30,328 · 9 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in THE's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
THE's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 40% higher than 60% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
| 2022 | 2 | 22.2% |
| 2024 | 4 | 44.4% |
Which technologies does THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center patent most?
Top 10 of 10 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Frequently Asked Questions
How many patents does THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center hold?
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center holds 9 US granted patents filed between 2020 and 2024, spanning 10 technology areas.
What is THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's Innovation Score?
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center has an Innovation Score of 38.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center focus on?
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 9 patents. The company has filed patents in 10 CPC subclasses total.
Is THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center.
What does claim depth mean for THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's patents?
THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center's patents average 10.3 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the THE Lundquist Institute FOR Biomedical Innovation AT Harbor-ucla Medical Center patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
THE's 9 grants land it in the top 40% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - THE ranks #30,324 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.